ISSN 2515-8260
 

Review Article 


Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication

P Scalia, SJ Williams, R Luca’, Antonio Giordano, E Bucci.

Abstract
The agent of Covid19, Sars-CoV-2 has caused
thousands of fatalities worldwide and overshadowed
the number of deaths of other previous coronavirus
outbreaks (Sars-CoV1 2002 and MERS-CoV 2012).
Although the new coronavirus pathogenicity is
actively under investigation, part of its infectious
behavior can be linked to its higher binding affinity
to the angiotensin-converting enzyme 2 (ACE2)
in the respiratory tracts. However, the expression
of ACE2 per se may not be sufficient to justify the
individual variability observed among affected
patients in terms of clinical outcome in apparently
non-immune depressed, non-elders subjects.
The present update provides an overview of the
most recent scientific findings related to genetic
factors involved in the Sars-CoV-2 infectious
process and their potential role in affecting the
virus pathogenicity. The present update can
provide valuable hints towards developing a
predictive screening/susceptibility profile testing
on individuals not yet infected and/or in nonsymptomatic
positive subjects towards managing
the current morbidity and mortality risk and
establishing personalized intervention protocols for
the early treatment of the Sars-CoV-2-associated
life-threatening pulmonary complication.

Key words: The morbidity and the mortality of Coronavirus infectious disease 19 (Covid19) (Zhou et al., 2020) is linked to lung failure observed in those subjects with pulmonary distress requiring intensive care treatment.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by P Scalia
Articles by SJ Williams
Articles by R Luca’
Articles by Antonio Giordano
Articles by E Bucci
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. EJMCM. 2020; 7(1): 05-09.


Web Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. http://www.ejmcm.com/?mno=116023 [Access: June 18, 2020].


AMA (American Medical Association) Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. EJMCM. 2020; 7(1): 05-09.



Vancouver/ICMJE Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. EJMCM. (2020), [cited June 18, 2020]; 7(1): 05-09.



Harvard Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci (2020) Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. EJMCM, 7 (1), 05-09.



Turabian Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. 2020. Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. European Journal of Molecular & Clinical Medicine, 7 (1), 05-09.



Chicago Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. "Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication." European Journal of Molecular & Clinical Medicine 7 (2020), 05-09.



MLA (The Modern Language Association) Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci. "Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication." European Journal of Molecular & Clinical Medicine 7.1 (2020), 05-09. Print.



APA (American Psychological Association) Style

P Scalia, SJ Williams, R Luca', Antonio Giordano, E Bucci (2020) Genetic and Cell biology Discriminants of Sars-CoV2 Infection and Susceptibility to Covid-19 pulmonary complication. European Journal of Molecular & Clinical Medicine, 7 (1), 05-09.